41st Pharmacovigilance USA 2026

41st Pharmacovigilance USA 2026 is organized by Virtue Insight and will be held from May 27 - 28, 2026 at Wyndham Boston Beacon Hill, Boston, Massachusetts, United States of America.

Focus Areas:

• Challenges / Opportunities
• Market Trends- Critiques & Ways Forward
• Patient Safety/ Patient Centricity
• Outsourcing
• Rwe / Rwd
• Rmp/ Rems
• Audits & Inspection
• Impact of Technology Ai, Ml, Da
• Quality, Safety & Signal Detection
• Automation in Pv
• Regulatory

Key Speakers:

• Mariette Boerstoel-streefland, Svp, Worldwide Patient Safety Officer, Bristol-myers Squibb
• Philisha Mack, Sr. Director of Drug Safety, Medical Affairs, Azurity Pharmaceuticals
• E. Alton Sartor, Medical Director, Patient Safety Physician Digital & Devices, Astrazeneca
• Nicole Schumacher-crow, Continuous Improvement Center of Excellence Head - Senior Director, Pfizer
• Harsha Shetty, Senior Director, Global Safety Lead & Patient Engagement, Csl Behring
• Karthik Muthusamy, Executive Director, Head of Us Patient Safety, Novo Nordisk
• Deanna Montes De Oca, Sr. Director, Global Head of Pv Operations Case Management, Moderna
• Wendy Erler, Svp Patient Affairs, Sarepta Therapeutics
• Eddie Darton, Vp - Head Global Pv & Risk Management, Sarepta Therapeutics
• Susan Wnorowski, Sr. Director, Us Medical Information and Patient Safety, Ipsen
• Shalini Patel, Sr. Director Pv Operations - Pharmacovigilance Center of Excellence, Moderna
• Michael Glaser, Technology Innovation Director, Gsk
• Michele Coiro, Director, Us Rems Strategy & Submissions, Bristol-myers Squibb
• Vasudev Bhupathi, Director – Pharmacovigilance, Moderna
• Manjiri Nirgudkar, Director; Global Process Lead - Global Risk Management, Bristol-myers Squibb
• Allison Concannon, Director, Global Patient Safety, Americas Lead, Ipsen
• Jian-yu E, Director of Pharmacoepidemiology, Patient Safety & Pv (Pspv), Sanofi
• Julie Barberio, Director, Pharmacoepidemiology, Sanofi
• Vikalp Khare, Director, Head of Us Gpv Safety Data Management, Otsuka Pharmaceutical
• Ashraf Youssef, Global Senior Medical Director, Post Marketed Products, Global Safety Lead, Takeda Pharmaceuticals
• Shefali Jobanputra, Associate Director, Cpass Compliance Process, and Training Lead, Takeda
• Teodora Doherty, Global Medical Safety (Gms), Medical Safety Officer, Janssen R&d
• Jillian Horvath, Associate Director, Global Rmp (Pharmacovigilance), Jazz Pharmaceuticals
• Ben Locwin, Vp Board of Directors, Sopphc (Vp, Reliant Life Sciences)
• Milind Sardesai, Executive Director, Safety Surveillance Global Patient Safety, Dicerna Pharmceuticals
• Sumit Munjal, Global Head of Medical Safety, Otsuka Pharmaceutical
• Kal Elhoregy, Director, Risk Evaluation and Mitigation Strategy (Rems) Programs, Amneal Pharmaceuticals
• William a. Blumentals, Head of Pharmacoepidemiology Specialty Care, Sanofi
• Priyanka Chhikara, Head of Risk Management, Aggregate Reports & Data Science, Csl Behring
• Mallika Singh, Associate Director, Pharmacovigilance, Genetix Biotherapeutics
• Kapil Bhutada, Head of Pv Safety Operation & Compliance, Asklepios Biopharmaceutical
• Anuj Parikh, Associate Medical Director, Medical Safety, Jazz Pharmaceuticals
• Namita Joshi, Regional Pv Head, North America, Opella
• Sandy Diaz, Owner & Principal Consultant, Pharmacovigilance Solutions
• Reem Yasin, Quality Assurance & Pv Manager, Hawkary Pharmaceuticals, Kawkab Group (Iraq)
• Heather Leigh Flannery, Ceo & Co-founder, Ai Mindsystems Foundation
• Vineet Singh, Head of Pv Data Science and Analytics, Csl Behring
• Nina Teo, Senior Manager, Global Patient Safety & Risk Management, Alnylam Pharmaceuticals